Paul J. Diaz, President and CEO at MYRIAD GENETICS INC (MYGN), sold 15,000 shares at $26.72 ($401K) on 2024-09-11, disclosed to the SEC on 2024-09-12.
Scheduled sale ($401k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DVA | SELL | 2020-05-19 | $923K | — | Filing → |
| KND | BUY | 2015-11-12 | $627K | — | Filing → |
| KND | SELL | 2014-03-07 | $2.5M | — | Filing → |